赛道掘金：聚焦高景气硬科技核心

Group 1: Electronic Industry - The electronic industry holds a weight of 33% in the Sci-Tech Innovation 200 index, with a positive outlook for 2026 driven by the dual forces of semiconductor self-sufficiency and AI innovation [1] - National policies are strongly supporting self-sufficiency in the electronic and semiconductor sectors, with the National Big Fund's third phase raising over 300 billion yuan, focusing on critical areas such as equipment and materials [1] - The continuous demand for AI computing power is a key driver, with domestic companies providing the necessary support for computing power, which is expected to benefit the electronic sector on the Sci-Tech Innovation Board [1] Group 2: Pharmaceutical Industry - The pharmaceutical industry accounts for approximately 20% of the index, with a core viewpoint that the value of Chinese innovative drugs is gaining international recognition, marking a critical turning point [2] - The Chinese pharmaceutical industry has undergone significant transformation over the past decade, with a full-chain support policy for innovative drugs set to elevate their development to a national strategic level [2] - The number of self-researched FIC drugs by Chinese companies has increased from 9 in 2015 to 120 in 2024, representing 31% of the global pipeline, second only to the United States [2][6] Group 3: Machinery and Equipment Industry - The machinery and equipment sector represents 12% of the index, benefiting from strong policy support and emerging growth trends, particularly in high-end manufacturing [6] - The "14th Five-Year Plan" emphasizes original innovation and key technology breakthroughs in industries such as integrated circuits and high-end instruments, which will drive growth in the machinery sector [6] - The commercial progress of robotics is expected to reach a turning point by 2026, with domestic supply chain changes and industrialization pace accelerating [7] Group 4: Investment Opportunities - The Guotai Sci-Tech 200 ETF (subscription code: 589223) fills the gap for small-cap allocations in the Sci-Tech Innovation Board, offering high growth potential and low entry barriers for investors [7]